Related Experiment Video
Updated: Oct 7, 2025
Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
Published on: November 3, 2023
Gastrointestinal Bleeding in Congenital Bleeding Disorders
Amir Samii1, Mahshaad Norouzi2, Abbas Ahmadi3
1Department of Hematology and Blood Transfusion, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran.
Insights
Gastrointestinal bleeding (GIB) in congenital bleeding disorders (CBDs) presents unique challenges due to varied patient responses. This review details current GIB management strategies and alternative therapies for CBDs, focusing on coagulation factor deficiencies and platelet disorders.
Area of Science:
- Gastroenterology
- Hematology
- Genetics
Background:
- Gastrointestinal bleeding (GIB) is a severe condition with diverse presentations in patients with congenital bleeding disorders (CBDs).
- Effective management of GIB in CBDs is complicated by phenotypic heterogeneity.
- Early identification and assessment are crucial for managing GIB in this population.
Purpose of the Study:
- To review current understanding of GIB in CBDs.
- To highlight recent findings on prevalence, management, and alternative therapies for GIB related to coagulation factor deficiencies (CFDs) and platelet disorders.
Main Methods:
- Literature review focusing on GIB in CBDs.
- Analysis of diagnostic approaches, including hematological assessment.
- Examination of treatment strategies, including replacement therapy and alternative options.
Main Results:
- GIB is rare but severe in CBDs, necessitating precise assessment.
- Initial evaluation involves hematological status assessment; GIB must be considered in patients with anemia or specific bleeding symptoms.
- Management for high-risk patients includes urgent interventions like replacement therapy for CFDs, though optimal strategies are debated.
Conclusions:
- Comprehensive assessment and tailored management are essential for GIB in CBDs.
- Further research is needed to clarify the best treatment strategies for CFD-related GIB.
- This review synthesizes current knowledge on GIB in CBDs, emphasizing CFDs and platelet disorders.
Abstract:
Gastrointestinal bleeding (GIB) is serious, intractable, and potentially life-threatening condition. There is considerable heterogeneity in GIB phenotypes among congenital bleeding disorders (CBDs), making GIB difficult to manage. Although GIB is rarely encountered in CBDs, its severity in some patients makes the need for a comprehensive and precise assessment of underlying factors and management approaches imperative. Initial evaluation of GIB begins with assessment of hematological status; GIB should be ruled out in patients with chronic anemia, and in presentations that include hematemesis, hematochezia, or melena. High-risk patients with recurrent GIB require urgent interventions such as replacement therapy for treatment of coagulation factor deficiency (CFD). However, the best management strategy for CFD-related bleeding remains controversial. While several investigations have identified CBDs as potential risk factors for GIB, research has focused on assessing the risks for individual factor deficiencies and other CBDs. This review highlights recent findings on the prevalence, management strategies, and alternative therapies of GIB related to CFDs, and platelet disorders.
Related Concept Videos
01:24Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
01:24Esophageal Varices-I: Introduction
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...